For Israeli public companies, a dual listing presents a powerful strategic leap. This approach opens doors to the world’s deepest capital pools. Consequently, it keeps your company firmly rooted in its home market.
The Strategic Edge of a Dual Listing
Maximizing global reach requires access to international capital and Wall Street’s attention. Therefore, a dual listing on TASE and NASDAQ provides a direct pipeline for Israel’s most promising public companies. This move gives you access to the incredible liquidity of U.S. markets. It also strengthens your standing within Israel’s dynamic economy.
This strategy builds a bridge between two innovative tech ecosystems. You capture the interest of major U.S. institutional investors. Moreover, you maintain the loyalty of Israeli investors. This dual presence dramatically boosts your corporate profile and market credibility.
Unlocking Higher Valuations and Deeper Liquidity
Unlocking higher valuations is a primary benefit for your company. Tapping into a larger investor base naturally increases demand for your shares. Consequently, this often drives your market cap far higher.
With shares trading on both exchanges, your daily trading volume gets a significant boost. This enhanced liquidity delivers greater stock stability and smoother capital raises. Subsequently, a NASDAQ listing also attracts prominent U.S. financial analyst coverage.
A dual listing is far more than a financial transaction. It is a public declaration to the global market. Your company is ready to meet the highest standards.
Israeli regulators have created a framework to make the dual listing TASE NASDAQ process more accessible. Specifically, they aligned reporting requirements to reduce administrative burdens. This lets your leadership team focus on growth, not duplicative filings. Before this complex move, a solid foundation in local law, such as the process for company registration, is vital.
Navigating the Dual Listing Arrangement Relief
To protect your company from unnecessary costs, you must understand Israel’s “Dual Listing” arrangement. This framework is a game-changer for public companies. It allows Israeli firms on major U.S. exchanges to adopt American reporting standards.
The result is a massive reduction in administrative burdens. The core benefit is simple: you file documents with the SEC. Those same filings then satisfy the Israel Securities Authority (ISA). This single-filing system eliminates redundant paperwork and parallel legal reviews. However, this relief is not a free pass to ignore certain critical Israeli laws.
Understanding Waived Reporting Obligations
Reducing compliance risk means leveraging reporting relief effectively. The biggest relief comes from routine financial and periodic reporting. Your ongoing obligations to the ISA are mostly fulfilled by submitting U.S. filings.
Specifically, your SEC-compliant quarterly (10-Q) and annual (10-K/20-F) reports satisfy Israeli requirements. Additionally, immediate reports on material events (8-K) meet Israel’s disclosure rules. This elegant solution ensures all investors receive the same high-quality information. For any company mapping a dual listing TASE NASDAQ strategy, this is a massive plus. Of course, a firm must first master the complexities of navigating the SEC maze.
The Dual Listing arrangement prevents a costly “double compliance” burden. It allows an Israeli company to operate under one primary set of rules. Therefore, it makes Israeli capital markets more attractive.
This efficiency is a powerful magnet for global companies. It was a key reason a giant like Palo Alto Networks announced its intention to dual-list on the TASE. Consequently, it can tap into Israel’s economy without disruptive compliance conflicts.
Key Israeli Obligations That Remain
To mitigate legal exposure, you cannot ignore duties under Israeli corporate law. The ISA keeps a tight grip on several key areas. A misstep here can create serious legal problems.
Specifically, Israeli law remains in charge for interested party transactions. These deals demand specific committee and shareholder approvals. Furthermore, the Israeli Companies Law governs tender offers and mergers. This includes mandatory thresholds designed to protect minority shareholders. Finally, shareholder meeting mechanics must follow Israeli law to the letter. This is particularly crucial when handling complex financial matters, such as suing banks over compliance failures.
Forging a Unified Corporate Governance
To ensure seamless operation, your company must fuse two distinct legal universes. An Israeli public company pursuing a dual listing on the TASE and NASDAQ steps into both Israeli and U.S. legal frameworks. This creates a formidable governance challenge.
Your goal is building a model that is compliant and efficient. Get this harmonization wrong, and the board exposes itself to legal blowback. The balancing act begins with board composition. For example, Israeli law mandates “external directors,” while NASDAQ listing rules demand a majority of “independent directors.” Their legal definitions have crucial differences.
The Board Composition Puzzle
To avoid conflicts, you must assemble a board that operates under two rule sets. Every candidate must qualify as “external” under Israeli law. Simultaneously, they must be “independent” by NASDAQ’s standards. This involves a deep dive into a candidate’s professional history. The committee structure must also meet both regulatory regimes.
A dual-listed company’s governance framework is its armor. It must withstand scrutiny from both the ISA and the SEC. This protects the company and its stakeholders.
Viewing this as a burden is a mistake; it is an opportunity. By adopting the highest standards from both jurisdictions, your company signals its commitment. This unified approach strengthens oversight and enhances shareholder value. Strong governance is also vital for managing financial complexities, such as issues with restricted bank accounts.
Navigating SOX and Israeli Law
To remain compliant, your company must adhere to the U.S. Sarbanes-Oxley Act. SOX introduced a new era of corporate accountability. Its rules directly impact internal controls and financial reporting. Your internal processes must meet these demanding U.S. requirements.
At the same time, you remain under the jurisdiction of the Israeli Companies Law. This includes strict regulations governing executive compensation and director duties. The real challenge is integrating these local rules with SOX requirements. For example, an executive compensation plan must satisfy both Israeli approval processes and SEC disclosure rules.
Navigating Strategic Delisting Procedures
To secure your company’s future, your strategy must include exit options. Understanding the legal playbook for delisting from TASE or NASDAQ is critical foresight. It prepares your company for its entire lifecycle. Therefore, you can act decisively when circumstances change.
A delisting decision is usually triggered by a major strategic event. For instance, a merger or a pivot to a single market might prompt it. In these moments, a clear delisting plan is crucial. This proactive planning protects shareholder value and market perception.
Initiating the Delisting Process
To begin the process, the company’s board of directors must pass a resolution. This requires a deep analysis of the long-term impact. The process then moves to regulatory notifications to the Israel Securities Authority (ISA) and the SEC.
Delisting from NASDAQ typically starts with filing a Form 25 with the SEC. This form officially signals your intent to remove the securities. The delisting becomes effective ten days after filing. However, your full reporting obligations may continue for some time.
Shareholder Approvals and Tender Offers
To protect minority shareholders, Israeli law adds a significant layer of complexity. A decision to delist from TASE almost always requires a special tender offer. This ensures shareholders have a fair chance to sell their shares. Consequently, it prevents inequitable outcomes for smaller investors.
The tender offer process under Israeli law is a powerful protection mechanism. It prevents controlling shareholders from forcing a delisting at an unfair valuation. Thus, it ensures an equitable exit for everyone involved.
The Israeli Companies Law details the specifics of the tender offer. This often requires a “special majority” approval from non-interested shareholders. Navigating these rules demands precise legal execution. This is especially true for companies with foreign ownership, where complexities resemble those in buying property in Israel.
Coordinated Regulatory Filings
To avoid legal liabilities, you must ensure seamless coordination. The filings with the SEC and the ISA must be perfectly synchronized. Any mismatch can create regulatory gaps or conflicting disclosures. This requires tight collaboration between your U.S. and Israeli legal teams.
Once the NASDAQ delisting is effective, you must manage the exit from TASE. This involves submitting the correct notifications to the TASE and the ISA. A strategic delisting, when handled correctly, is a powerful tool. A mismanaged process, however, can destroy shareholder value.
For expert legal guidance on executing a dual listing or delisting strategy, Contact our firm for a consultation.
The information provided is for general informational purposes only and does not constitute legal advice. Reliance on the information contained herein is at the reader’s sole responsibility.